Cryptosporidium infection in patients with primary immunodeficiencies

Journal of Pediatric Gastroenterology and Nutrition

Volumn 45, Issue 4, 2007, Pages 458-464

  Wolska Kusnierz, Beata ^a,d   Bajer, Anna ^a   Caccio, Simone ^b   Heropolitanska Pliszka, Edyta ^a   Bernatowska, Ewa ^a   Socha, Piotr ^a   Van Dongen, Jacques ^c   Bednarska, Malgorzata ^a   Paziewska, Anna ^a   Sinski, Edward ^a  

^a UNIVERSITY OF WARSAW   (Poland)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Cryptosporidium species; Hyperimmunoglobulin M syndrome; Primary immunodeficiencies; Sclerosing cholangitis

Indexed keywords

ANALYTIC METHOD; ARTICLE; CHILD; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; CRYPTOSPORIDIUM HOMINIS; CRYPTOSPORIDIUM MELEAGRIDIS; CRYPTOSPORIDIUM PARVUM; DIAGNOSTIC PROCEDURE; FECES ANALYSIS; FEMALE; GENOTYPE; HUMAN; HYPER IGM SYNDROME; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE; INFANT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; OOCYST; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; FATAL OUTCOME; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPER-IGM IMMUNODEFICIENCY SYNDROME; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULINS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; MALE; PAROMOMYCIN; POLAND; RETROSPECTIVE STUDIES; T-LYMPHOCYTOPENIA, IDIOPATHIC CD4-POSITIVE;

CRYPTOSPORIDIUM;

EID: 37349017582     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318054b09b     Document Type: Article

References (37)

1. Huang DB, Chappell C, Okhuysen PC. Cryptosporidiosis in children. Semin Pediatr Infect Dis 2004;15:253-9.
2. Siński E, Szklarczyk J, Oralewska B, et al. Cryptosporidium sp. infection in childrenwith symptomsof gastro-enteritis. Acta Parasitol Polon 1988;33:295-301.
3. Neill MA, Rice SK, Ahmad NV, et al. Cryptosporidiosis: anunrecognised cause of diarrhoea in elderly hospitalised patients. Clin Infect Dis 1996;22:168-70.
4. Kocoshis SA, Cibull ML, Davis TE, et al. Intestinal and pulmonary cryptosporidiosis in an infant with severe combined immune deficiency. J Pediatr Gastroenetrol Nutr 1984;3:149-57.
5. Levy J, Espanol-Boren T, Thomas C. Clinical spectrum of X linked hyper-IgM syndrome. J Pediatr 1997;131:47-54.
6. Davies EG, Hadzic N, Jones AM. Cholangiopathy in children with combined immunodeficiencies [abstract]. Mol Immunol 1998;35:731.
7. Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev 2002;15:145-54.
8. Thompson RC, Olson ME, Zhu G, et al. Cryptosporidium and cryptosporidiosis. Adv Parasitol 2005;59:77-158.
9. Cacciò SM, Thompson RCA, McLauchlin J, et al. Unravelling Cryptosporidium and Giardia epidemiology. Trends Parasitol 2005;21:430-7.
10. O'Donoghoue PJ. Cryptosporidium and cryptosporidiosis in man and animals. Int J Parasitol 1995;25:139-95.
11. Cello JP. Human immunodeficiency virus associated biliary tract disease. Semin Liver Dis 1992;12:213-8.
12. Clark DP. New insights into human cryptosporidiosis. Clin Microbiol Rev 1999;12:554-63.
13. Henriksen S, Pohlenz J. Staining of cryptosporidia by modified Ziehl-Neelsen technique. Acta Vet Scand 1981;22:594-6.
14. Da Silva AJ, Bornay-Llinares FJ, Moura INS, et al. Fast and reliable extraction of protozoan parasite DNA from fecal specimens. Mol Diag 1999;4:57-64.
15. Pedraza-Diaz S, Amar C, Nichols GL, et al. Nested polymerase chain reaction for amplification of the Cryptosporidium oocyst wall protein gene. Emerg Infect Dis 2001;7:49-56.
16. Spano F, Putignani L, McLauchlin J, et al. PCR-RFLP analysis of the Cryptosporidium oocyst wall protein (COWP) gene discriminates between C. wrairi and C. parvum, and between C. parvum isolates of human and animal origin. FEMS Microbiol Lett 1997;150:209-17.
17. Xiao L, Limor J, Morgan UM, et al. Sequence differences in the diagnostic target region of the oocyst wall protein gene of Cryptosporidium parasites. Appl Environ Microbiol 2000;66:5499-502.
18. Fayer R, Speer CA, Dubey JP. The general biology of cryptosporidium. In: Fayer R (ed). Cryptosporidium and Cryptosporidiosis. Boca Raton, FL: CRC Press; 1997:1-41.
19. Chen W, Harp JA, Harmsen AG, et al. Gamma interferon functions in resistance to Cryptosporidium parvum infection in SCID mice. Infect Immunol 1993;61:3548-51.
20. McDonald V, Bancroft GJ. Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice. Parasite Immunol 1994;16:315-20.
21. Perryman LE, Mason PH, Chrisp CE. Effect of spleen cell populations on resolution of Cryptosporidium parvum infection in SCID mice. Adv Parasitol 1998;40:87-119.
22. Ungar BLP, Kao TC, Burris JA, et al. Cryptosporidium infection in an adult mouse model. Independent roles for IFNγ and CD4+T lymphocytes in protective immunity. J Immunol 1991;147:1014-22.
23. Ferrari S, Giliani S, Insalco A, et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Nat Acad Sci U S A 2001;98:12614-9.
24. Winkelstein JA, Marino MC, Ochs H, et al. The X-linked hyper-IgM syndrome. Medicine 2003;82:373-84.
25. McLauchlin J, Amar C, Pedraza-Diaz S, et al. Molecular epidemiological analysis of Cryptosporidium spp. in the United Kingdom: results of genotyping Cryptosporidium spp. in 1705 fecal samples from humans and 105 fecal samples from livestock animals. J Clin Microbiol 2000;38:3984-90.
26. Caccio S, Pinter E, Fantini R, et al. Human infection with Cryptosporidium felis: case report and literature review. Emerg Infect Dis 2002;8:85-6.
27. Sargent KD, Morgan UM, Elliot A, et al. Morphological and genetic characterisation of Cryptosporidium oocysts from domestic cats. Vet Prasitol 1998;7:221-7.
28. Fayer R, Ttout JM, Xiao L, et al. Cryptosporidium canis n. sp. from domestic dogs. J Parasitol 2001;87:1415-22.
29. Slavin D. Cryptosporidium meleagridis (sp. Nov.). J Comp Pathol Ther 1955;65:262-6.
30. Toniati P, Savoldi G, Jones AM, et al. Report of the ESID collaborative study on clinical features and molecular analysis of X-linked hyper-IgM syndrome. Eur Soc Immunodeficiencies Newslett 2002;F9 (Suppl):40.
31. Gennery AR, Khawaja K, Veys P, et al. Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002. Blood 2004;103:1152-7.
32. Heyward AR, Levy J, Facchetti F, et al. Cholangiopathy and tumors of the pancreas, liver and biliary tree in boys with X-linked immunodeficiency with hyper IgM. J Immunol 1997;158:977-83.
33. Zulu I, Kelly P, et al. Nitazoxanide for persistent diarrhoea in Zambian acquired immune deficiency syndrome patients: a randomized-controlled trial. Aliment Pharmacol Ther 2005; 21:757-63;
34. Notarangelo LD, Hayward AR, X-linked immunodeficiency with hyper IgM (XHIM). Clin Exp Immunol. 2000;120:399-405.
35. Dimicoli S, Benesoussan D, Latger-Cannard V, et al. Complete recovery from Cryptosporidium parvum infection with gastroenterocolitis and sclerosis cholangitis after successful bone marrow transplantation in two brothers with X-linked hyper-IgM syndrome. Bone Marrow Transplant 2003;32:733-7.
36. Rodrigues F, Davies EG, Harrison P, et al. Liver disease in children with primary immunodeficiencies. J Pediatr 2004;145:333-9.
37. Kutukculer N, Moratto D, Aydinok Y, et al. Disseminated Cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency. J Pediatr 2003;142:194-6.